Detalles de la búsqueda
1.
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Breast Cancer Res Treat
; 204(1): 61-68, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964135
2.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902335
3.
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
Br J Cancer
; 125(10): 1443-1449, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34408284
4.
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
Breast Cancer Res Treat
; 183(3): 759-770, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32734520
5.
Ductal carcinoma in situ: to treat or not to treat, that is the question.
Br J Cancer
; 121(4): 285-292, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31285590
6.
Feasibility of Micro-Computed Tomography Imaging for Direct Assessment of Surgical Resection Margins During Breast-Conserving Surgery.
J Surg Res
; 241: 160-169, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31026794
7.
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.
NPJ Breast Cancer
; 8(1): 60, 2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35523804
8.
Variability in grading of ductal carcinoma in situ among an international group of pathologists.
J Pathol Clin Res
; 7(3): 233-242, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620141
9.
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review.
Breast
; 50: 95-103, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32120064
10.
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
NPJ Breast Cancer
; 6: 15, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436923
11.
Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore.
Clin Cancer Res
; 25(16): 4985-4992, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31076546
12.
Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen.
Virchows Arch
; 475(2): 191-199, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31264038
Resultados
1 -
12
de 12
1
Próxima >
>>